Fred has extensive operational and fundraising experience, including the development of corporate partnerships and the structuring of venture capital investments and acquisitions.Prior to founding CLS, Fred was the chief executive officer and then chairman of Heska(HSKA). During his tenure at Heska, Fred completed corporate partnerships with Bayer and Novartis, completed seven acquisitions and HeskaÃ¯Â¿Â½s initial public offering and follow-on public offering. During this time, Heska also obtained its first FDA approval, launched its first products, created its sales and marketing effort and grew its revenue to approximately $40 million.Fred has also been the president and chief executive officer of Mingly Capital Corporation,which was focused on developing cross-border opportunities in life sciences and information technology. He was also executive director of the Mingly Corporation Limited(listed on the Hong Kong Stock Exchange) and prior to that he was a senior vice president of C.M. Capital,a diversified asset management company.Fred began his professional career as an attorney representing technology companies and venture capitalists. In 1985, he was made a partner with Pillsbury, Madison & Sutro (now Pillsbury, Winthrop) and in 1988 he founded the firm of General Counsel Associates (now GCA Law Partners).Fred holds a JD from the University of California, Berkeley, Boalt Hall School of Law and a BA from the University of Michigan.
Amaranth Medical, APT Pharmaceuticals, Kereos, Minimally Invasive Devices, and Visioneering Technologies